Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus) is a Human Full Length protein, in the 1 to 898 aa range, expressed in Baculovirus infected Sf9 cells, with >80%, suitable for SDS-PAGE, WB, FuncS.
View Alternative Names
DPRP1, MSTP097, MSTP135, MSTP141, DPP8, Dipeptidyl peptidase 8, DP8, Dipeptidyl peptidase IV-related protein 1, Dipeptidyl peptidase VIII, Prolyl dipeptidase DPP8, DPRP-1, DPP VIII
- FuncS
Unknown
Functional Studies - Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus) (AB79662)
Specific Activity 22.4 pmol/min/μg. Determined using 10 μM Ala-Pro-AMC substrate.
- WB
Unknown
Western blot - Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus) (AB79662)
All lanes:
Western blot - Anti-DPP8 antibody (<a href='/en-us/products/primary-antibodies/dpp8-antibody-ab96470'>ab96470</a>) at 1/1000 dilution
All lanes:
Western blot - Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus) (ab79662) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 103 kDa,90 kDa
true
Exposure time: 3min
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant human DPP8 protein (GST tag N-Terminus + His tag N-Terminus) (AB79662)
SDS-PAGE showing ab79662 at approximately 129kDa (4μg).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DPP8 seems to play roles in modulating immune responses and cell proliferation. It functions independently and is not typically part of a larger protein complex. Studies suggest a connection between DPP8 and cellular processes such as apoptosis and inflammation although the exact biological roles require more detailed investigation.
Pathways
The peptidase activity of DPP8 integrates within metabolic and immune system pathways. In the context of metabolism it relates closely to proteins like DPP4 which influences glucose homeostasis. In immune pathways DPP8 regulates the processing of peptides affecting immune cell communication and activity sharing roles with other immune-related proteases.
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2 (PubMed : 11012666, PubMed : 12534281, PubMed : 12662155, PubMed : 15039077, PubMed : 15664838, PubMed : 20536396, PubMed : 29382749). Acts as a key inhibitor of caspase-1-dependent monocyte and macrophage pyroptosis in resting cells by preventing activation of NLRP1 and CARD8 (PubMed : 27820798, PubMed : 29967349, PubMed : 32796818). Sequesters the cleaved C-terminal part of NLRP1 and CARD8, which respectively constitute the active part of the NLRP1 and CARD8 inflammasomes, in a ternary complex, thereby preventing their oligomerization and activation (PubMed : 33731929, PubMed : 33731932, PubMed : 34019797). The dipeptidyl peptidase activity is required to suppress NLRP1 and CARD8; however, neither NLRP1 nor CARD8 are bona fide substrates of DPP8, suggesting the existence of substrate(s) required for NLRP1 and CARD8 inhibition (By similarity).
Sequence similarities
Belongs to the peptidase S9B family. DPPIV subfamily.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The FEBS journal 282:3737-57 PubMed26175140
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com